Correlación entre las edades cronológica y ósea en pacientes de ortodoncia / Correlation between the chronological and bone ages in orthodontics patients

Nos propusimos determinar la edad ósea según sexo y edad cronológica e identificar la relación existente entre las edades cronológica y ósea, en los pacientes estudiados. Se realizó un estudio descriptivo y transversal en un universo constituido por todos los niños y adolescentes tributarios de tratamiento ortodóncico, que ingresaron en la Clínica de Ortodoncia de la Facultad de Estomatología de la Universidad de Ciencias Médicas de La Habana, en el periodo de enero de 2004 a diciembre de 2006. El grupo etáreo se encontraba entre 8 y 16 años, de donde se seleccionó una muestra de 150 pacientes, mediante un muestreo por cuotas. A cada paciente se le realizó una radiografía de la mano izquierda, donde se determinó la edad ósea, a través del método de Tanner-Whitehouse 2 (TW2) y se calculó la correlación entre la edad ósea y la cronológica a través del coeficiente de correlación lineal de Pearson. Se encontraron correlaciones altas muy significativas entre las edades cronológica y ósea, en ambos sexos; sexo femenino r= 0,977 y masculino r= 0,983 (p< 0,010). La edad ósea de los pacientes calculada a través del método TW2, no coincidió con la edad cronológica, de manera que llegamos a la conclusión de que existe en ambos sexos, una correlación positiva alta entre las edades cronológica y ósea(AU)

To determine the bone age according to the sex and chronologic age and to identify the relation between the chronologic and bone ages in study patients. A cross-sectional and descriptive study was conducted in a universe including all children and adolescents needing orthodontics treatment admitted in the Orthodontics Clinic of the Stomatology Faculty of the Higher Institute of Medical Sciences (HIMS)-Habana from January, 2004 to December, 2006 aged between 8 and 16 selecting a sample including 150 patients by admission sampling, each patient undergoes a left hand radiography to determine the bone age by Tanner-Whitehouse 2 method (TW2) estimating the correlation between the bone age and chronologic one trough Pearson linear correlation coefficient. There were high and very significant correlations between the bone ages and the chronologic one in both sexes, female sex r= 0.977 and male sex r= 0.983 (p < 0.010). The bone age of patients estimated by TW2 method, not to coincided with the chronologic age and in both sexes there was a high positive correlation between above mentioned ages(AU)

Incidence, Timing of Screening Examinations and Perinatal Risk Factors for Retinopathy of Prematurity in Very Low Birth Weight Infants / 대한주산의학회잡지

OBJECTIVE: This study was conducted to evaluate the incidence, the optimal timing of screening examinations for retinopathy of prematurity(ROP) and to analyze perinatal risk factors associated with cryotherapy or lasertherapy(CT/LT) in ROP. METHODS: Medical records of 130 very low birth weight(VLBW) infants who admitted to the NICU of Wonkwang University Hospital from July 1997 to June 2002 were reviewed retrospectively. We evaluated the incidence and severity of ROP by gestational age(GA) and birth weight(BW). And the comparisons of perinatal risk factors between ROP with and without CT/LT have been made. RESULTS: Incidence of ROP was 36.9% and mean GA and BW were 29.1+/-1.99 weeks, 1,153+/-209 gm in VLBW infants respectively. ROP Stage II or greater was 15.4% of VLBW infants, 41.7% of ROP infants, and 27.1% of ROP infants were treated with CT/LT. All infants with BW <750gm or GA <26 weeks were developed ROP with stage II or greater and treated with CT/LT. First detection of ROP was performed at chronologic age(CA) 3 weeks, postconceptional age(PCA) 30 weeks, and first identification of threshold ROP needed with CT/LT were at CA 5 weeks and PCA 33 weeks. The perinatal risk factors with CT/LT for ROP were significant in GA, BW, Apgar score at 1 and 5 minutes and number of blood transfusion. The mean time of spontaneous regression is 13.4+/-8.8 weeks in the mild ROP infants without CT/LT. CONCLUSION: The incidence of ROP is 36.9% and the optimal timing of screening for ROP should be selected by earlier time in 2 guidelines of at 5 weeks of CA and 33 weeks of PCA in VLBW infants. And the related risk factors with CT/LT for threshold ROP were GA, BW and Apgar score at 1 and 5 minutes and number of blood transfusions.

Serum Peak Growth Hormone and Insulin like Growth Factor-I(IGF-I) Level After Insulin, L-dopa Provocation Test in Children with Constitutional Delay of Growth and Puberty / 대한소아내분비학회지

PURPOSE:There were many controversies whether constitutional delay of growth and puberty(CDGP) is simple varient of normal growth pattern, or one of the cause of growth disturbance induced by the disturbance of growth hormone secrtion or its function. So we studied about the difference in serum peak growth hormone level after insulin, L-dopa provocation test, and serum IGF-I leve between constitutional delay of growth and puberty(CDGP) and familial short stature(FSS). METHODS:Measurement of serum peak growth hormone and insulin like growth factor-I(IGF-I) level after insulin, L-dopa provocation test were performed in 33 children with costitutional delay of growth and puberty (CDGP). Two groups of children with familial short stature (FSS) whose height were below 10 percentile for chronologic age of Korean national height standards were included as control groups. RESULTS: 1)There were no significant difference of serum peak growth hormone level between children with CDGP and children with FSS and these results were similar in both sex. 2)The mean serum IGF-I level of children with CDGP were 125.69+/-4.06 ng/ml(71.53-189.34ng/ml) in male, 157.7+/-3.17ng/ml(81.9-279.2ng/ml) in female. Both results were significantly lower to those of FSS children by chronologic age group because the mean serum IGF-I level of FSS children were 190.19+/-7.97ng/ml (87.64-297.6ng/ml) in male, 205.47+/-15.87ng/ml(61.7-433.1ng/ml) in female. But compared to FSS children by bone age of 72-96 months, there were no significant difference noted because the mean serum IGF-I level of children with FSSwere130.47+/-0.27ng/ml(63.24-198.2ng/ml)inmale,162.35+/-9.43ng/ml(54.9-217.53 ng/ml) in female. CONCLUSIONS:The results of this study showed that the serum peak growth hormone level after insulin, L-dopa provocation test with children of CDGP revealed no significant difference with those of FSS children in both sex. Serum IGF-I level of CDGP children was lower significantly to those of FSS children by chronologic age group, but no much difference with FSS children of bone age group.